Corporate Vision January 2017

40 CORPORATE VISION / January 2017 , Simon Moyes specialises in arthroscopic and minimally invasive treatment for mainly sports injuries specialising on problems for the knee, shoulder, foot and ankle. He is a pioneer of arthroscopic surgery taking up the post of Consultant Orthopaedic Surgeon at UCL Hospitals in 1994 with a special interest there in arthroscopic surgery and sports medicine.In 1998 he moved into full time private practice, which he continues to offer to this day. Simon’s overall mission is to ensure the patient is happy and Small Details Make Big Differences SimonMoyes is a leading Consultant Orthopaedic Surgeon practising out of TheWellington Hospital in St John’sWood and a branch of London Bridge Hospital in the City at 31 Old Broad Street. We profile Simon and his work, exploring howhe aims to provide the very best support and care to his clients in this vital sector. informed at all times – he believes this is all part of an efficient recovery plan. The patient has access to members of the team at all times to ask questions and they take the time to understand the patient’s situation in-depth. Medically, they aim to reduce the need for surgery and if surgery is required, then it usually minimally invasive such as key-hole or arthroscopy where there is a quicker recovery time. In order to ensure full satisfaction and provide the very highest standard of client service, when patients call Simon Moyes’ office they are greeted by a person, not an answer phone. Every effort is made to see the patient on that day, and to ensure they receive same day scans. By the end of the day the patient can expect a diagnosis at which point a treatment programme is set out for the patient and the overwhelming majority of patients are treated conservatively/non- operatively. The team at the practice has been working together for 15 years and are highly experienced in ensuring patients are aware of the whole process. After the operation, should it be required, the patient would typically come back for consultations (on average twice) to ensure their recovery is smooth as their aftercare is as important as the treatment itself. After discharge, Simon is always happy to help with any problems or questions that may arise, ensuring that clients are supported throughout the process. Within the wider healthcare industry, the latestmedical devices and technology are offering real benefits to patients, for example arthroscopic technology is permanently evolving and making the surgeons life easier. Simon works closely with a couple of companies called Arthrex and Smith & Nephew, both of whom have developed excellent tools for making it easier for surgeons to carry out cartilage repair surgery. Smith & Nephew also have developed a new device, a form of radio frequency probe which enable certain types of arthroscopic surgery to be carried out faster and more effectively. This is valuable in knee, shoulder and arthroscopic hip surgery. Developments are also happening in the area of reconstructive surgery and that we are now allowed to use bone marrow derived aspirate concentration to augment cartilage and ligament repairs. This aspirate is rich in stem cells and whilst still experimental is believed to enhance cartilage, ligament and tendon repair and can also be used to treat arthritis. As such, in order to ensure the continued success of his practice, Simon will continue to maintain his current high standards of practice, integrate the latest developments and innovations into his work to ensure he is always offering the very highest standard of service to his patients. A particular growth area is that of medical tourism with an increasing number of patients flying in from outside of the UK to London which is a large hub for medical tourism and the want for treatment with him. These are certainly growth areas in patient numbers and he is seeing an increase in the number of patients coming in from the UAE and the African Sub Continent. Simon’s future plans also include increasing development and usage of stem cell based technologies to improve outcomes and to potentially establish a stem cell bank. 1612CV42